Galactosylated chitosan-graft-polyethylenimine as a gene carrier for hepatocyte targeting. 2007

H-L Jiang, and J-T Kwon, and Y-K Kim, and E-M Kim, and R Arote, and H-J Jeong, and J-W Nah, and Y-J Choi, and T Akaike, and M-H Cho, and C-S Cho
1Department of Agricultural Biotechnology, Research Institute for Agriculture and Life Sciences, Seoul National University, Seoul, Korea.

Chitosans have been proposed as alternative, biocompatible cationic polymers for nonviral gene delivery. However, the low transfection efficiency and low specificity of chitosan need to be addressed before clinical application. We prepared galactosylated chitosan-graft-polyethylenimine (GC-g-PEI) copolymer by an imine reaction between periodate-oxidized GC and low-molecular-weight PEI. The molecular weight and composition were characterized using gel permeation chromatography column with multi-angle laser scattering and (1)H nuclear magnetic resonance, respectively. The copolymer was complexed with plasmid DNA in various copolymer/DNA (N/P) charge ratios, and the complexes were characterized. GC-g-PEI showed good DNA-binding ability and superior protection of DNA from nuclease attack and had low cytotoxicity compared to PEI 25K. GC-g-PEI/DNA complexes showed higher transfection efficiency than PEI 25K in both HepG2 and HeLa cell lines. Transfection efficiency into HepG2, which has asialoglycoprotein receptors, was higher than that into HeLa, which does not. GC-g-PEI/DNA complexes also transfected liver cells in vivo after intraperitoneal (i.p.) administration more effectively than PEI 25K. These results suggest that GC-g-PEI can be used in gene therapy to improve transfection efficiency and hepatocyte specificity in vitro and in vivo.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011094 Polyethyleneimine Strongly cationic polymer that binds to certain proteins; used as a marker in immunology, to precipitate and purify enzymes and lipids. Synonyms: aziridine polymer; Epamine; Epomine; ethylenimine polymer; Montrek; PEI; Polymin(e). Polyaziridine,Polyethylenimine,Polyaziridines,Polyethyleneimines,Polyethylenimines
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H-L Jiang, and J-T Kwon, and Y-K Kim, and E-M Kim, and R Arote, and H-J Jeong, and J-W Nah, and Y-J Choi, and T Akaike, and M-H Cho, and C-S Cho
June 2005, Journal of controlled release : official journal of the Controlled Release Society,
H-L Jiang, and J-T Kwon, and Y-K Kim, and E-M Kim, and R Arote, and H-J Jeong, and J-W Nah, and Y-J Choi, and T Akaike, and M-H Cho, and C-S Cho
October 2000, Journal of controlled release : official journal of the Controlled Release Society,
H-L Jiang, and J-T Kwon, and Y-K Kim, and E-M Kim, and R Arote, and H-J Jeong, and J-W Nah, and Y-J Choi, and T Akaike, and M-H Cho, and C-S Cho
October 2001, Journal of controlled release : official journal of the Controlled Release Society,
H-L Jiang, and J-T Kwon, and Y-K Kim, and E-M Kim, and R Arote, and H-J Jeong, and J-W Nah, and Y-J Choi, and T Akaike, and M-H Cho, and C-S Cho
February 2007, Journal of controlled release : official journal of the Controlled Release Society,
H-L Jiang, and J-T Kwon, and Y-K Kim, and E-M Kim, and R Arote, and H-J Jeong, and J-W Nah, and Y-J Choi, and T Akaike, and M-H Cho, and C-S Cho
April 2003, International journal of pharmaceutics,
H-L Jiang, and J-T Kwon, and Y-K Kim, and E-M Kim, and R Arote, and H-J Jeong, and J-W Nah, and Y-J Choi, and T Akaike, and M-H Cho, and C-S Cho
June 2009, International journal of pharmaceutics,
H-L Jiang, and J-T Kwon, and Y-K Kim, and E-M Kim, and R Arote, and H-J Jeong, and J-W Nah, and Y-J Choi, and T Akaike, and M-H Cho, and C-S Cho
January 2016, Journal of drug targeting,
H-L Jiang, and J-T Kwon, and Y-K Kim, and E-M Kim, and R Arote, and H-J Jeong, and J-W Nah, and Y-J Choi, and T Akaike, and M-H Cho, and C-S Cho
January 2013, Drug design, development and therapy,
H-L Jiang, and J-T Kwon, and Y-K Kim, and E-M Kim, and R Arote, and H-J Jeong, and J-W Nah, and Y-J Choi, and T Akaike, and M-H Cho, and C-S Cho
December 2004, Archives of pharmacal research,
H-L Jiang, and J-T Kwon, and Y-K Kim, and E-M Kim, and R Arote, and H-J Jeong, and J-W Nah, and Y-J Choi, and T Akaike, and M-H Cho, and C-S Cho
July 2007, Die Pharmazie,
Copied contents to your clipboard!